Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
03/31/2011 | CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors |
03/31/2011 | CA2775133A1 Pyrido[3,4-b]indoles and methods of use |
03/31/2011 | CA2775129A1 Pyrido[3,4-b]indoles and methods of use |
03/31/2011 | CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
03/31/2011 | CA2770087A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 1oa inhibitors |
03/30/2011 | EP2301939A1 Enzyme inhibitors |
03/30/2011 | EP2301936A1 Spirodiamine-diarylketoxime derivative |
03/30/2011 | EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors |
03/30/2011 | EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose |
03/30/2011 | EP2300477A1 Tricyclic nitrogen containing compounds and their use as antibacterials |
03/30/2011 | EP2300476A1 Tricyclic nitrogen containing compounds and their use as antibacterials |
03/30/2011 | EP2300475A1 Diazacarbazoles and methods of use |
03/30/2011 | EP2300474A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists |
03/30/2011 | EP2300473A2 Fumarate salt of 4-bromophenyl 1,4-diazabicycloý3.2.2¨nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof |
03/30/2011 | EP2300472A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
03/30/2011 | EP2300471A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides |
03/30/2011 | EP2300470A2 Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators |
03/30/2011 | EP2300469A2 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
03/30/2011 | EP2300468A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido ý 3, 2, 1-i j¨quinoline compounds |
03/30/2011 | EP2300467A2 Novel and improved processes for the preparation of paliperidone |
03/30/2011 | EP2300466A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
03/30/2011 | EP2300465A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases |
03/30/2011 | EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists |
03/30/2011 | EP2300438A1 Imidazole derivatives useful as inhibitors of faah |
03/30/2011 | EP2300436A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs |
03/30/2011 | EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
03/30/2011 | EP2299824A1 Pyrazole derivatives useful as inhibitors of faah |
03/30/2011 | EP2299816A1 Inhibitors of janus kinases |
03/30/2011 | EP2299813A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists |
03/30/2011 | EP2176259B1 Fused imidazoles for cancer treatment |
03/30/2011 | EP2057125B1 Non-nucleoside reverse transcriptase inhibitors |
03/30/2011 | EP1940835B1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
03/30/2011 | EP1804919B1 Cgrp receptor antagonists |
03/30/2011 | EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
03/30/2011 | EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
03/30/2011 | CN101993443A Novel crystal form of benzilic acid nortropine easter and preparation method thereof |
03/30/2011 | CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds |
03/30/2011 | CN101279969B Organic electroluminescent material and application thereof |
03/29/2011 | US7915411 Anti-viral compounds |
03/29/2011 | US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
03/29/2011 | US7915284 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
03/29/2011 | US7915283 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
03/29/2011 | US7915281 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method |
03/29/2011 | US7915280 Compounds and their uses |
03/29/2011 | US7915264 Drugs for treating pain formed by arylation |
03/29/2011 | US7914908 Organic electroluminescent device having an azatriphenylene derivative |
03/29/2011 | US7914706 Charge transport compositions and electronic devices made with such compositions |
03/29/2011 | US7914703 exhibit high fluorescence in inks; useful for security taggant applications |
03/29/2011 | CA2543250C Process for the preparation of ccr-2 antagonist |
03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
03/29/2011 | CA2483752C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity |
03/29/2011 | CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
03/29/2011 | CA2443672C Aryl and biaryl piperidines used as mch antagonists |
03/29/2011 | CA2436980C Amido ether substituted imidazoquinolines |
03/29/2011 | CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
03/29/2011 | CA2428223C Compounds and methods for promoting smoking cessation |
03/24/2011 | WO2011034954A1 Treatment of cancer |
03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
03/24/2011 | WO2011034078A1 Glycine compound |
03/24/2011 | WO2011033230A1 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof |
03/24/2011 | WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
03/24/2011 | WO2011033055A1 Fused triazole amines as p2x7 modulators |
03/24/2011 | WO2011010842A3 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
03/24/2011 | WO2011008725A3 Metal-catalyzed carbon-fluorine bond formation |
03/24/2011 | WO2010123583A3 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof |
03/24/2011 | US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
03/24/2011 | US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
03/24/2011 | US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
03/24/2011 | US20110071180 Sub-type selective amides of diazabicycloalkanes |
03/24/2011 | US20110071174 Substituted quinazolines |
03/24/2011 | US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
03/24/2011 | US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF |
03/24/2011 | US20110071155 Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
03/24/2011 | US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof |
03/24/2011 | US20110071147 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
03/24/2011 | US20110071143 Fused triazole amines as p2x7 modulators |
03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
03/24/2011 | US20110071128 Novel imidazopyridines |
03/24/2011 | US20110070595 Methods for the identification of parp interacting molecules and for purification of parp proteins |
03/24/2011 | US20110070317 Pyrrolopyridines as kinase inhibitors |
03/24/2011 | US20110070297 Glucokinase activators |
03/24/2011 | US20110068012 Biosensor and method of detection of a dna sequence |
03/24/2011 | CA2774266A1 Novel tricyclic protein kinase modulators |
03/24/2011 | CA2774148A1 Tricyclic compounds and pharmaceutical uses thereof |
03/24/2011 | CA2773985A1 Protein kinase conjugates and inhibitors |
03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
03/24/2011 | CA2772689A1 Glycine compound |
03/24/2011 | CA2772105A1 Fused triazole amines as p2x7 modulators |
03/23/2011 | EP2299509A1 Organic electroluminescent device |
03/23/2011 | EP2298775A1 Diazabicyclic central nervous system active agents |
03/23/2011 | EP2298768A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer |
03/23/2011 | EP2298767A1 Nitrogenated bicyclic heterocyclic compound |
03/23/2011 | EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
03/23/2011 | EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
03/23/2011 | EP2298739A1 Organic light emitting device containing polycyclic heteroaryl compounds |
03/23/2011 | EP2297274A1 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics |
03/23/2011 | EP2297150A1 Substituted quinazolines as blood platelet lowering agents |
03/23/2011 | EP2297149A1 Process for preparation of tadalafil |